Dr. Dino PratoEnvita Medical Centers · Founder and CEO at Envita Medical Centers

How Precision Monitoring Helps Prevent Cancer Relapse

6 Nov 2025 · 1 min

Watch on YouTube

0:37

In this brief presentation, the speaker explains how precision monitoring of very early breast cancer can be used to predict disease‑free and overall survival. By measuring circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) after tumor removal, a negative result indicates a very low risk of relapse. The speaker then shifts to a root‑cause approach, arguing that addressing metabolic disturbances, immune dysfunction, infections, chemical toxins, and heavy metals can further reduce relapse risk and simultaneously lower the likelihood of other chronic conditions such as heart disease, diabetes, and Alzheimer’s. The overall message is that precise biomarker monitoring combined with lifestyle and environmental interventions can both prevent cancer recurrence and improve overall health.

Chapters

This is how we begin to eliminate cancer. So we can independently predict disease free and overall survival in this very early breast cancer monitoring. Because if we have a negative CTDNA and CTC after it's been removed, there's so much of a low chance for relapse, which is exactly what we want. And we can now focus on metabolic factors, immune system infections, chemical toxins, heavy metals, any of these positive agents. With root cause analysis, we can also build the immune system. And by the way, when you do those things, you're also reducing risk for heart disease, diabetes, Alzheimer's, because these same heavy metals, chemical toxins, infections, metabolic problems with poor diet, inflammation, are linked to heart disease, diabetes, cancer,